This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Sporadic and Familial Acute Myeloid Leukemia with CEBPA Mutations
Current Hematologic Malignancy Reports Open Access 01 June 2023
-
The complex genetic landscape of familial MDS and AML reveals pathogenic germline variants
Nature Communications Open Access 25 February 2020
-
Female reproductive potential after oncological treatment: a rare case report of acute myeloid leukemia in monozygotic twin sisters with literature review
Journal of Ovarian Research Open Access 03 January 2020
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Smith ML, Cavenagh JD, Lister TA, Fitzgibbon J . Mutation of CEBPA in familial acute myeloid leukemia. N Engl J Med 2004; 351: 2403–2407.
Radomska HS, Huettner CS, Zhang P, Cheng T, Scadden DT, Tenen DG . CCAAT/enhancer binding protein alpha is a regulatory switch sufficient for induction of granulocytic development from bipotential myeloid progenitors. Mol Cell Biol 1998; 18: 4301–4314.
De Lord C, Powles R, Mehta J, Wilson K, Treleaven J, Meller S et al. Familial acute myeloid leukaemia: four male members of a single family over three consecutive generations exhibiting anticipation. Br J Haemat 1998; 100: 557–560.
Sellick GS, Pritchard-Jones K, Shepherd V, Swansbury J, Catovsky D, Houlston RS . Loci other than 21q22.12 (RUNX1) and 16q21–23.2 cause familial AML. Leukemia 2005; 19: 465–466.
Schwieger M, Lohler J, Fischer M, Herwig U, Tenen DG, Stocking C . A dominant-negative mutant of C/EBPalpha, associated with acute myeloid leukemias, inhibits differentiation of myeloid and erythroid progenitors of man but not mouse. Blood 2004; 103: 2744–2752.
Leroy H, Roumier C, Huyghe P, Biggio V, Fenaux P, Preudhomme C . CEBPA point mutations in hematological malignancies. Leukemia 2005; 19: 329–334.
Acknowledgements
We are grateful to the family who participated in this study. This work was supported by grants from the Leukaemia Research Fund (GSS, RSH and DC) and Cancer Research UK (KP-J, and RSH).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sellick, G., Spendlove, H., Catovsky, D. et al. Further evidence that germline CEBPA mutations cause dominant inheritance of acute myeloid leukaemia. Leukemia 19, 1276–1278 (2005). https://doi.org/10.1038/sj.leu.2403788
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2403788
This article is cited by
-
Sporadic and Familial Acute Myeloid Leukemia with CEBPA Mutations
Current Hematologic Malignancy Reports (2023)
-
Female reproductive potential after oncological treatment: a rare case report of acute myeloid leukemia in monozygotic twin sisters with literature review
Journal of Ovarian Research (2020)
-
The complex genetic landscape of familial MDS and AML reveals pathogenic germline variants
Nature Communications (2020)
-
Preleukemia: one name, many meanings
Leukemia (2017)
-
Overexpression of wild-type or mutants forms of CEBPA alter normal human hematopoiesis
Leukemia (2012)